Celgene bet $1 billion that this biotech's science can cure deadly cancers

Medical DailyCelgene bet $1 billion that this biotech's science can cure deadly cancersFortuneOn Tuesday, the biotech ponied up $1 billion to gain access to innovative cancer treatments being developed by Juno Therapeutics. The deal gives Celgene a 10% stake in Juno, as well the rights to sell the company's therapies around the world. It's the ...Celgene pays $1 billion for stake in Juno cancer researchSFGateCelgene To Invest $1 Billion In Juno To Partner In Cancer TherapiesMedical DailyCelgene and Juno announce ten-year cancer dealPMLiVEall 161 news articles »

Share this post